Arsen Osipov
Medical Director, Pancreatic Cancer, Cedars- Sinai · Cedars-Sinai Medical Center
Credentials: · · · ·
History
PresentPancreatic Cancer · Cedars-Sinai Medical Center
- Present
- 2016–2018
Medical Oncology
- 2009–2013
Research
Tipping the immunostimulatory and inhibitory DAMP balance to harness immunogenic cell death
Nature Communications · 2020 · 223 citations
Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape
Review · Journal for ImmunoTherapy of Cancer · 2019 · First of 4 authors · 197 citations
Recent advances in the management of hepatocellular carcinoma
Review · Clinical and Molecular Hepatology · 2024 · 140 citations
51 papers
35 papers
22 papers
16 papers
15 papers
13 papers · 4 as a fellow
13 papers
12 papers
Grants
- 2021–2026
Targeting the Stroma for Pancreatic Cancer Treatment
National Cancer Institute · K08
Contact PI · $1.2M · Cedars-Sinai Medical Center
Clinical trials
- 2026–2027
Phase I Study of Cosibelimab and Balixafortide in Metastatic Pancreatic Ductal Adenocarcinoma
Principal investigator · Not yet recruiting · Phase 1
Arsen Osipov
- 2018–2024
Principal investigator · Completed · Phase 2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- 2019–2025
Study chair · Completed · Phase 2
Lei Zheng
- 2026–2028
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
Site PI · Recruiting · Phase 2
Verastem, Inc.